2024 Global Therapeutic Drug Monitoring (TDM) Market for 28 Assays--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Competitive Landscape, Innovative Technologies, Instrumentation Review, Opportunities for Suppliers
This new 313-page report from LeadingMarketResearch.com contains 83 tables and provides analysis of the global therapeutic drug monitoring testing market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares, and strategic profiles of leading suppliers.The report is available by section, and can be customized to specific information needs and budget.The report provides test volume and sales forecasts by country and market segment for the following assays:AmikacinCarbamazepineCyclosporinDigoxinEverolimusGentamicinLevetiracetamLithiumMethotrexateNAPA/ProcainamidePhenobarbitalPhenytoinQuinidineSirolimusTacrolimusTheophyllineTobramycinTopirimateValproic AcidVancomycinDuring the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlying technology. This evolving marketplace will create exciting opportunities for a variety of new instruments, reagent systems, and auxiliary products, such as specimen preparation devices, controls, calibrators and others.This report is a unique worldwide market and technology assessment designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities and developed effective strategic responses. The study provides five-year forecasts for major TDM assays; compares features of leading analyzers; and profiles key competitors.Contains 313 pages and 83 tables
Introduction
Worldwide Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
The report provides segment test volume and sales forecasts for the following tests:
Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran,
Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium,
Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban,
Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin
and Warfarin.
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC
analyzers manufactured by Abaxis, Abbott, Alfa
Wassermann, AMS, Awareness Technologies, Beckman
Coulter, Binding Site, bioMerieux, Carolina Chemistries,
DiaSorin, Grifols, Horiba, Medica, Nova Biomedical,
Ortho-Clinical Diagnostics, Polymedco, Randox, Roche,
Siemens Healthineers, Tosoh, Vital Diagnostics and
other suppliers.
C. Major In Vitro Diagnostic Technologies
And Their Potential
Applications
1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. TANDEM MASS SPEC
4. IT AND AUTOMATION
5. DRY CHEMISTRY
6. BIOSENSORS
Table of Contents (Continued)
France: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Germany: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Italy: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Japan: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Worldwide Market and Technology Overview
A. Major Therapeutic Drug Monitoring Tests
The report provides segment test volume and sales forecasts for the following tests:
Amikacin, Apixaban, Argatroban, Betrixaban, Carbamazepine, Cyclosporin, Dabigatran,
Digoxin, Edoxaban, Everolimus, Fluindione, Gentamicin, Levetiracetam, Lithium,
Methotrexate, NAPA/Procainamide, Phenobarbital, Phenytoin, Quinidine, Rivaroxaban,
Sirolimus, Tacrolimus, Theophylline, Tobramycin, Topirimate, Valproic Acid, Vancomycin
and Warfarin.
B. Instrumentation Review: Operating characteristics and
features of high-, medium-, and low-volume/POC
analyzers manufactured by Abaxis, Abbott, Alfa
Wassermann, AMS, Awareness Technologies, Beckman
Coulter, Binding Site, bioMerieux, Carolina Chemistries,
DiaSorin, Grifols, Horiba, Medica, Nova Biomedical,
Ortho-Clinical Diagnostics, Polymedco, Randox, Roche,
Siemens Healthineers, Tosoh, Vital Diagnostics and
other suppliers.
C. Major In Vitro Diagnostic Technologies
And Their Potential
Applications
1. MONOCLONAL AND POLYCLONAL ANTIBODIES
2. IMMUNOASSAYS
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays
° Overview
° ELISA
° EMIT
° Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
3. TANDEM MASS SPEC
4. IT AND AUTOMATION
5. DRY CHEMISTRY
6. BIOSENSORS
Table of Contents (Continued)
France: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Germany: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Italy: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
Japan: Test Volume and Sales Forecasts by Assay and Market
Segment, And Major Supplier Market Shares
